Parmax Pharma Ltd. (PARMAX)
Market Open
11 Aug, 22:00
MSE MSE Primary ₹
111. 00
+2.15
+1.9752%
₹
103.82M Market Cap
- P/E Ratio
- Div Yield
151 Volume
0 Eps
₹ 108.85
Previous Close Want to track PARMAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
PARMAX trading today higher at ₹111, an increase of 1.9752% from yesterday's close, completing a monthly increase of 39.3247% or ₹31.33. Over the past 12 months, PARMAX stock gained 229.7683%.
PARMAX is not paying dividends to its shareholders.
The last earnings report, released on May 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
PARMAX Chart
People also search for
Parmax Pharma Ltd. (PARMAX) FAQ
What is the stock price today?
The current price is ₹111.00.
On which exchange is it traded?
Parmax Pharma Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is PARMAX.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 103.82M.
Has Parmax Pharma Ltd. ever had a stock split?
No, there has never been a stock split.
Parmax Pharma Ltd. Profile
| Pharmaceuticals Industry | Healthcare Sector | - CEO | MSE Exchange | INE240T01014 ISIN |
| India Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Parmax Pharma Ltd. is a pharmaceutical company engaged in the research, development, and manufacturing of generic and branded pharmaceutical products. Its primary function is to provide affordable and accessible medication across various therapeutic areas, including cardiovascular, neurological, and respiratory illnesses. Known for its strong commitment to innovation, the company continuously invests in research and development to enhance its product portfolio and address unmet medical needs. Parmax Pharma Ltd. serves a broad spectrum of markets, including hospitals, clinics, and pharmacies around the globe. Its strategic market presence and distribution channels enable the efficient delivery of cost-effective healthcare solutions. As a significant player in the pharmaceutical sector, Parmax Pharma Ltd. contributes to the industry's growth and evolution by focusing on quality, compliance with regulatory requirements, and sustainable business practices. The company's efforts towards expanding its production capacities and embracing technological advancements underscore its pivotal role in the healthcare landscape, impacting both emerging and established economies.
Contact Information
Address: Plot No. 20, Survey No. 52
Phone: 91 28 2727 0534
Website: https://www.parmaxpharma.com
